Cellectis (CLLS) Long-Term Deferred Tax (2024 - 2026)

Cellectis (CLLS) posted quarterly Long-Term Deferred Tax of $382000.0 for Q1 2026, little changed year-over-year from $382000.0 in Q1 2025, and little changed quarter-over-quarter from $382000.0 in Q4 2025.

Cellectis (CLLS) Long-Term Deferred Tax (2024 - 2026) Analysis & Trends

Cellectis' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $382000.0 for Q1 2026.

  • In Q1 2026, Long-Term Deferred Tax changed 0.0% year-over-year to $382000.0; the TTM figure through Mar 2026 stood at $382000.0 (changed 0.0% YoY), while the FY2025 annual figure was $382000.0, changed 0.0% from the prior year.
  • Long-Term Deferred Tax for Q1 2026 stood at $382000.0, roughly flat from $382000.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $803000.0 in Q3 2024, with the low at $382000.0 in Q4 2024.
  • The 3-year median for Long-Term Deferred Tax is $382000.0 (2024), against an average of $442142.9.
  • Peak annual rise in Long-Term Deferred Tax reached 0.0% in 2025, while the deepest fall reached 52.43% in 2025.
  • Cellectis' Long-Term Deferred Tax stood at $382000.0 in 2024, then changed by 0.0% to $382000.0 in 2025, then changed by 0.0% to $382000.0 in 2026.
  • Business Quant data shows CLLS's Long-Term Deferred Tax at $382000.0 in Q1 2026, $382000.0 in Q4 2025, and $382000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Cellectis 306.61 Mn 120.95 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 382,000.00
Dec 31, 2025 382,000.00
Sep 30, 2025 382,000.00
Jun 30, 2025 382,000.00
Mar 31, 2025 382,000.00
Dec 31, 2024 382,000.00
Sep 30, 2024 803,000.00